Brookfield Asset Management Inc. Astrazeneca PLC Transaction History

Brookfield Asset Management Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	SELL	$69.91 - $75.81 $5.53 Million - $6 Million	-79,122 Reduced 24.46%	244,353 $17.5 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $5.53 Million - $6 Million	-79,122 Reduced 24.46%	244,353 $17.5 Million
Q1 2023 Sep 25, 2023	BUY	$63.15 - $71.6 $5 Million - $5.67 Million	79,122 Added 32.38%	323,475 $22.5 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $4.76 Million - $5.4 Million	75,360 Added 30.37%	323,475 $22.5 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $6.06 Million - $7.88 Million	111,868 Added 82.11%	248,115 $16.8 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $485,981 - $1.24 Million	9,166 Added 7.21%	136,247 $7.47 Million
Q2 2022 Nov 16, 2022	SELL	$59.26 - $71.14 $543,177 - $652,069	-9,166 Reduced 6.73%	127,081 $8.4 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $10.5 Million - $12.7 Million	-177,933 Reduced 58.34%	127,081 $8.4 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $9.61 Million - $11.4 Million	177,849 Added 139.86%	305,014 $17.8 Million
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $2.4 Million - $2.62 Million	43,130 Added 51.32%	127,165 $7.64 Million
Q2 2021 Aug 17, 2021	BUY	$48.42 - $60.18 $4.07 Million - $5.06 Million	84,035 New	84,035 $5.03 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.